Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
0I5P.L Stock Summary
In the News
0I5P.L Financial details
Company Rating
Neutral
Market Cap
3.73B
Income
-105.37M
Revenue
31.07M
Book val./share
2.58
Cash/share
3.48
Dividend
-
Dividend %
-
Employees
101
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-26.89
Forward P/E
-34.19
PEG
14.65
P/S
53.08
P/B
7.43
P/C
9.33
P/FCF
-42.4
Quick Ratio
22.31
Current Ratio
22.76
Debt / Equity
0.37
LT Debt / Equity
0.34
-
-
EPS (TTM)
-0.99
EPS next Y
-0.95
EPS next Q
-0.4
EPS this Y
-18.18%
EPS next Y
-4.27%
EPS next 5Y
-382.71%
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
15.63%
-
-
-
-
SMA20
12.48%
SMA50
39.47%
SMA100
135.58%
Inst Own
-
Inst Trans
-
ROA
-20%
ROE
-63%
ROC
-0.19%
Gross Margin
-33%
Oper. Margin
-161%
Profit Margin
-176%
Payout
-
Shs Outstand
66.44M
Shs Float
96.64M
-
-
-
-
Target Price
-
52W Range
0.0-32.45
52W High
-
52W Low
-
RSI
82.44
Rel Volume
0.96
Avg Volume
2.72K
Volume
2.61K
Perf Week
0.12%
Perf Month
35.45%
Perf Quarter
-
Perf Half Y
109.28%
-
-
-
-
Beta
0.32
-
-
Volatility
0.01%, 3.2%
Prev Close
0%
Price
32.48
Change
0%
0I5P.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0 | 0 | 0 | 0.29 | |
Net income per share | -1.53 | -0.74 | -1.27 | -1.21 | -0.99 | |
Operating cash flow per share | -1.46 | -0.65 | -0.98 | -0.96 | -0.68 | |
Free cash flow per share | -1.47 | -0.65 | -0.98 | -0.96 | -0.69 | |
Cash per share | 2.85 | 2.12 | 2.63 | 1.54 | 3.71 | |
Book value per share | 2.78 | 2.07 | 1.87 | 0.41 | 2.75 | |
Tangible book value per share | 2.78 | 2.07 | 1.87 | 0.41 | 2.75 | |
Share holders equity per share | 2.78 | 2.07 | 1.87 | 0.41 | 2.75 | |
Interest debt per share | 0.01 | 0.01 | 0.75 | 1.2 | 1.21 | |
Market cap | 406.89M | 400.27M | 227.38M | 546.14M | 2.53B | |
Enterprise value | 384.17M | 373.82M | 153.15M | 616.77M | 2.44B | |
P/E ratio | -3.96 | -7.85 | -2.53 | -5.15 | -24.02 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 81.45 | |
POCF ratio | -4.16 | -8.95 | -3.27 | -6.5 | -34.89 | |
PFCF ratio | -4.14 | -8.95 | -3.27 | -6.48 | -34.68 | |
P/B Ratio | 2.18 | 2.8 | 1.71 | 15.11 | 8.66 | |
PTB ratio | 2.18 | 2.8 | 1.71 | 15.11 | 8.66 | |
EV to sales | 0 | 0 | 0 | 0 | 78.49 | |
Enterprise value over EBITDA | -3.76 | -7.1 | -1.76 | -6.67 | -24.15 | |
EV to operating cash flow | -3.92 | -8.36 | -2.21 | -7.34 | -33.62 | |
EV to free cash flow | -3.91 | -8.35 | -2.2 | -7.32 | -33.42 | |
Earnings yield | -0.25 | -0.13 | -0.4 | -0.19 | -0.04 | |
Free cash flow yield | -0.24 | -0.11 | -0.31 | -0.15 | -0.03 | |
Debt to equity | 0 | 0 | 0.38 | 2.51 | 0.37 | |
Debt to assets | 0 | 0 | 0.25 | 0.64 | 0.25 | |
Net debt to EBITDA | 0.22 | 0.5 | 0.85 | -0.76 | 0.91 | |
Current ratio | 11.51 | 15.38 | 10.41 | 8.94 | 10.96 | |
Interest coverage | 0 | 0 | -33.91 | -6.25 | -5.37 | |
Income quality | 0.95 | 0.88 | 0.77 | 0.79 | 0.69 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 2.58 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0.01 | |
Capex to revenue | 0 | 0 | 0 | 0 | -0.01 | |
Capex to depreciation | -0.39 | -0.03 | -0.13 | -0.21 | -0.65 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 9.79 | 5.87 | 7.3 | 3.34 | 7.84 | |
ROIC | -0.55 | -0.37 | -0.47 | -0.73 | -0.25 | |
Return on tangible assets | -0.5 | -0.33 | -0.44 | -0.75 | -0.24 | |
Graham Net | 2.57 | 1.97 | 1.65 | 0.34 | 2.37 | |
Working capital | 185.29M | 141.73M | 172.73M | 122.63M | 366.96M | |
Tangible asset value | 186.35M | 142.71M | 132.94M | 36.15M | 292.26M | |
Net current asset value | 183.54M | 140.47M | 121.72M | 32.38M | 261.37M | |
Invested capital | 0 | 0 | 0.38 | 2.51 | 0.37 | |
Average receivables | 343.5K | 482K | 138.5K | 0 | 0 | |
Average payables | 2.24M | 1.37M | 1.48M | 1.91M | 2.46M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 1.14K | 133.41 | 1.45K | 563.44 | 2.05K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.32 | 2.74 | 0.25 | 0.65 | 0.18 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.55 | -0.36 | -0.68 | -2.93 | -0.36 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.23 | 0 | 0.3 | 0 | 0 | |
Net income per share | -0.3 | -0.29 | -0.01 | -0.32 | -0.37 | |
Operating cash flow per share | -0.21 | 0.07 | -0.25 | -0.25 | -0.24 | |
Free cash flow per share | -0.21 | 0.06 | -0.25 | -0.25 | -0.24 | |
Cash per share | 1.54 | 2.41 | 2.09 | 4.15 | 3.48 | |
Book value per share | 0.41 | 1.06 | 1.06 | 3.09 | 2.58 | |
Tangible book value per share | 0.41 | 1.06 | 1.06 | 3.09 | 2.58 | |
Share holders equity per share | 0.41 | 1.06 | 1.06 | 3.09 | 2.58 | |
Interest debt per share | 1.08 | 1.02 | 1.02 | 1.03 | 1.01 | |
Market cap | 546.15M | 834.71M | 1.13B | 1.6B | 2.7B | |
Enterprise value | 616.78M | 870.73M | 1.2B | 1.43B | 2.61B | |
P/E ratio | -5.13 | -7.25 | -350.51 | -11.83 | -16.11 | |
Price to sales ratio | 26.96 | 0 | 36.52 | 0 | 47.38K | |
POCF ratio | -29.12 | 129.8 | -44.54 | -61.34 | -98.63 | |
PFCF ratio | -29.1 | 133.85 | -44.41 | -61.34 | -97.99 | |
P/B Ratio | 15.11 | 8.01 | 10.45 | 4.92 | 9.24 | |
PTB ratio | 15.11 | 8.01 | 10.45 | 4.92 | 9.24 | |
EV to sales | 30.44 | 0 | 38.59 | 0 | 45.76K | |
Enterprise value over EBITDA | -26.48 | -32.64 | 10.69K | -44.83 | -61.46 | |
EV to operating cash flow | -32.88 | 135.4 | -47.06 | -54.86 | -95.27 | |
EV to free cash flow | -32.86 | 139.63 | -46.93 | -54.86 | -94.65 | |
Earnings yield | -0.05 | -0.03 | 0 | -0.02 | -0.02 | |
Free cash flow yield | -0.03 | 0.01 | -0.02 | -0.02 | -0.01 | |
Debt to equity | 2.51 | 0.91 | 0.92 | 0.32 | 0.37 | |
Debt to assets | 0.64 | 0.39 | 0.44 | 0.23 | 0.25 | |
Net debt to EBITDA | -3.03 | -1.35 | 572.68 | 5.3 | 2.17 | |
Current ratio | 8.94 | 5.22 | 12.52 | 22.76 | 10.96 | |
Interest coverage | -5.76 | -6.1 | -0.02 | -6.65 | -8.36 | |
Income quality | 0.7 | -0.22 | 31.48 | 0.77 | 0.65 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.36 | 0 | 0.37 | 0 | 0 | |
Research and developement to revenue | 0.79 | 0 | 0.62 | 0 | 398.12 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | -0.03 | 0 | 0 | 0.01 | |
Capex to revenue | 0 | 0 | 0 | 0 | -3.16 | |
Capex to depreciation | -0.07 | -0.98 | -0.33 | 0 | -3.21 | |
Stock based compensation to revenue | 0.12 | 0 | 0.11 | 0 | 0 | |
Graham number | 1.68 | 2.65 | 0.43 | 4.72 | 4.63 | |
ROIC | -0.18 | -0.13 | 0 | -0.07 | -0.1 | |
Return on tangible assets | -0.19 | -0.12 | 0 | -0.08 | -0.1 | |
Graham Net | 0.34 | 0.97 | 0.94 | 2.97 | 2.22 | |
Working capital | 122.63M | 196.22M | 206.18M | 427.99M | 366.96M | |
Tangible asset value | 36.15M | 104.19M | 108.41M | 326.19M | 292.26M | |
Net current asset value | 32.38M | 101.59M | 105.83M | 322.8M | 261.37M | |
Invested capital | 2.51 | 0.91 | 0.92 | 0.32 | 0.37 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 787.5K | 1.36M | 3.11M | 3.66M | 3.28M | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 533.19 | 738.54 | 1.96K | 1.14K | 6.15K | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0.17 | 0.12 | 0.05 | 0.08 | 0.01 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | -0.74 | -0.28 | -0.01 | -0.1 | -0.14 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
0I5P.L Frequently Asked Questions
What is CymaBay Therapeutics, Inc. stock symbol ?
CymaBay Therapeutics, Inc. is a US stock , located in Newark of Ca and trading under the symbol 0I5P.L
What is CymaBay Therapeutics, Inc. stock quote today ?
CymaBay Therapeutics, Inc. stock price is $32.48 today.
Is CymaBay Therapeutics, Inc. stock public?
Yes, CymaBay Therapeutics, Inc. is a publicly traded company.